跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA/METFORMINA MYLAN 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA/METFORMINA MYLAN 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA/METFORMINA MYLAN 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Mylan Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 21, 2022
Approval ID
42d706f912bebb10
Company
Mylan Ireland Limited
Type
Standard
Approval Details
Approval Id
42d706f912bebb10
Drug Cima Aemps Name
SITAGLIPTINA/METFORMINA MYLAN 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
1211619013
Holder Company Name
Mylan Ireland Limited
Marketing Company Name
Viatris Pharmaceuticals S.L.
Holder Company Detail Path
/organization/mylan-ireland-limited
Authorization Date
2022-04-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 MG/1000 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Mylan Ireland Limited
Company Detail Path
/organization/mylan-ireland-limited
Company Information
Pharmaceutical Company Name
MYLAN IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
Legal Department
Website
http://www.mylan.ie
Active Ingredients
METFORMINA HIDROCLORURO
1000 mg
SITAGLIPTINA HIDROCLORURO
56,687 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 21, 2022
Approval ID
42d706f912bebb10
Type
Standard
Back to CIMA-AEMPS Approvals